Deciphera Pharmaceuticals, Inc.
Hedge Funds Holdings
Last updated:
Deciphera Pharmaceuticals, Inc.‘s stocks are currently a part of 117 hedge funds’ portfolios, which represents 75.02% of the total amount of its stocks outstanding. This makes up a total of 43.58M shares of Deciphera Pharmaceuticals, Inc.. Compared to the previous quarter, the number fell by -5.09% or -2.33M shares fewer. As for the holding position changes, 33.33% (39) of current hedge fund investors increased the number of shares held, 35.04% (41) of current holders sold a part of the shares held, and 29.91% (35) closed the holdings completely. 18 hedge funds are new holders of Deciphera Pharmaceuticals, Inc. stock in Q1 2022, it is 15.38% of total holders.
Hedge funds holding Deciphera Pharmaceuticals (Q3 2017 – Q1 2022)
| Q3 2017 | 50 |
|---|---|
| Q4 2017 | 59 |
| Q1 2018 | 55 |
| Q2 2018 | 90 |
| Q3 2018 | 88 |
| Q4 2018 | 78 |
| Q1 2019 | 80 |
| Q2 2019 | 83 |
| Q3 2019 | 121 |
| Q4 2019 | 151 |
| Q1 2020 | 145 |
| Q2 2020 | 165 |
| Q3 2020 | 158 |
| Q4 2020 | 180 |
| Q1 2021 | 161 |
| Q2 2021 | 141 |
| Q3 2021 | 158 |
| Q4 2021 | 134 |
| Q1 2022 | 117 |
Hedge funds changes in Deciphera Pharmaceuticals positions (Q3 2017 – Q1 2022)
| Q3 2017 | 50 | 0 | 0 | 0 | 0 |
|---|---|---|---|---|---|
| Q4 2017 | 31 | 14 | 9 | 22 | -17 |
| Q1 2018 | 10 | 21 | 16 | 14 | -6 |
| Q2 2018 | 42 | 26 | 14 | 7 | 1 |
| Q3 2018 | 15 | 36 | 22 | 17 | -2 |
| Q4 2018 | 15 | 31 | 19 | 25 | -12 |
| Q1 2019 | 11 | 25 | 26 | 9 | 9 |
| Q2 2019 | 16 | 36 | 17 | 10 | 4 |
| Q3 2019 | 49 | 48 | 18 | 11 | -5 |
| Q4 2019 | 46 | 61 | 35 | 14 | -5 |
| Q1 2020 | 31 | 58 | 41 | 35 | -20 |
| Q2 2020 | 33 | 68 | 46 | 14 | 4 |
| Q3 2020 | 16 | 63 | 54 | 22 | 3 |
| Q4 2020 | 34 | 70 | 51 | 12 | 13 |
| Q1 2021 | 20 | 59 | 55 | 38 | -11 |
| Q2 2021 | 12 | 54 | 52 | 31 | -8 |
| Q3 2021 | 29 | 50 | 51 | 11 | 17 |
| Q4 2021 | 26 | 58 | 31 | 50 | -31 |
| Q1 2022 | 18 | 39 | 41 | 35 | -16 |
Hedge funds changes in Deciphera Pharmaceuticals stock options (Q3 2017 – Q1 2022)
| Q3 2017 | 0 | 0 |
|---|---|---|
| Q4 2017 | 0 | 0 |
| Q1 2018 | 0 | 0 |
| Q2 2018 | 0 | 0 |
| Q3 2018 | 352,000 | 0 |
| Q4 2018 | 243,000 | 0 |
| Q1 2019 | 0 | 0 |
| Q2 2019 | 778,000 | 20,461,000 |
| Q3 2019 | 5,444,000 | 8,869,000 |
| Q4 2019 | 62,335,000 | 49,834,000 |
| Q1 2020 | 15,031,000 | 8,160,000 |
| Q2 2020 | 24,867,000 | 23,380,000 |
| Q3 2020 | 22,845,000 | 21,317,000 |
| Q4 2020 | 24,405,000 | 14,750,000 |
| Q1 2021 | 14,637,000 | 8,540,000 |
| Q2 2021 | 11,528,000 | 7,334,000 |
| Q3 2021 | 17,679,000 | 3,234,000 |
| Q4 2021 | 19,050,000 | 3,569,000 |
| Q1 2022 | 3,850,000 | 190,000 |